These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 32766169)

  • 1. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
    Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
    Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota.
    Xu J; Chen HB; Li SL
    Med Res Rev; 2017 Sep; 37(5):1140-1185. PubMed ID: 28052344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
    Chen Y; Wang M
    Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
    Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota: A new target for T2DM prevention and treatment.
    Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
    Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
    Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites.
    Chen S; Jiao Y; Han Y; Zhang J; Deng Y; Yu Z; Wang J; He S; Cai W; Xu J
    Acta Diabetol; 2024 Apr; 61(4):393-411. PubMed ID: 38227209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
    Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
    Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites.
    Wang D; Liu J; Zhou L; Zhang Q; Li M; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():905171. PubMed ID: 35909556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy.
    Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
    Sci Total Environ; 2020 Nov; 742():140429. PubMed ID: 32629250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-targeted therapies for type 2 diabetes mellitus: A review.
    Xu TC; Liu Y; Yu Z; Xu B
    World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between herbal medicines and gut microbiota in metabolic diseases.
    Wang L; Gou X; Ding Y; Liu J; Wang Y; Wang Y; Zhang J; Du L; Peng W; Fan G
    Front Pharmacol; 2023; 14():1105405. PubMed ID: 37033634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.
    Zhang B; Liu K; Yang H; Jin Z; Ding Q; Zhao L
    Front Cell Infect Microbiol; 2022; 12():855075. PubMed ID: 35433500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
    Tian J; Bai B; Gao Z; Yang Y; Wu H; Wang X; Wang J; Li M; Tong X
    Front Cell Infect Microbiol; 2021; 11():740236. PubMed ID: 34692563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Natural Soluble Polysaccharides on the Type 2 Diabetes through Modulating Gut Microbiota: A Review.
    Yang L; Li L; Wu X; Cai W; Lin Q; Zhu D; Liu H
    Curr Med Chem; 2021; 28(26):5368-5385. PubMed ID: 33687877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.